Bio-Techne Corp (TECH) Ordinary USD0.01

Sell:$58.63Buy:$58.66Price increased$0.85 (1.48%)

NASDAQ:Price increased1.96%
Market closed |
Prices delayed by at least 15 minutes
Sell:$58.63
Buy:$58.66
Change:Price increased$0.85 (1.48%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$58.63
Buy:$58.66
Change:Price increased$0.85 (1.48%)
Market closed |
Prices delayed by at least 15 minutes

Company Information

About this company

Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of purified proteins and reagent solutions, most notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents and T-Cell activation technologies. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, blood gas and clinical chemistry controls and other reagents for OEM and clinical customers. This segment also manufactures and sells fully automated multiomic spatial biology instrumentation and advanced tissue-based in-situ hybridization assays (ISH) for research and clinical use.

Key people

Robert V. Baumgartner
Independent Chairman of the Board
Joseph D. Keegan
Independent Director
Kim Kelderman
President, Chief Executive Officer, Director
James T. Hippel
Chief Financial Officer, Executive Vice President - Finance
Steve Crouse
President - Diagnostics and Spatial Biology Segment
William Alexander Geist
President - Protein Sciences
Shane Bohnen
Senior Vice President, General Counsel, Corporate Secretary
Julie L. Bushman
Independent Director
Amy E. Herr
Independent Director
John L. Higgins
Independent Director
Click to see more

Key facts

  • Shares in issue
    156.45m
  • EPIC
    TECH
  • ISIN
    US09073M1045
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    $9.00bn
  • Employees
    3,100
  • Exchange
    NASDAQ
  • Index
    S&P 500, TR Equity United States Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.